Broad Spectrum HPV Vaccine Dose Ranging Study (V502-001)
Broad Spectrum HPV Vaccine Dose Ranging Study (V502-001)
This dose-ranging study is to evaluate an investigational vaccine with the following
 objectives: (1) To demonstrate that the vaccine is well-tolerated in women (2) To evaluate
 immune responses in women who are between 16 and 23 years of age at enrollment.
Inclusion Criteria:

 -  Lifetime history of 0-4 sexual partners

 Exclusion Criteria:

 -  History of abnormal PAP test or abnormal cervical biopsy result; history of external
 genital/vaginal warts; history of positive HPV test